Literature DB >> 6700269

Morphologic heterogeneity of malignant lymphomas developing in mycosis fungoides.

S R Scheen, P M Banks, R K Winkelmann.   

Abstract

From an extensive series of patients with mycosis fungoides, we identified 12 in whom subsequently developing extracutaneous (lymph nodal) lymphoma manifested morphologic features other than those of so-called cutaneous T-cell lymphoma. Six patients had features diagnostic of Hodgkin's disease, two had morphologic and cytochemical features consistent with T-cell lymphoma but without the morphologic features ascribed to cutaneous T-cell type, and four had morphologic characteristics most consistent with B-cell lymphoma. Although in most cases of mycosis fungoides the lymphomas exhibit morphologically distinctive features of mycosis cells, we propose that in occasional cases this morphologic correlation is not present.

Entities:  

Mesh:

Year:  1984        PMID: 6700269     DOI: 10.1016/s0025-6196(12)60243-2

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Hodgkin's disease complicating non-Hodgkin's lymphoma.

Authors:  G X Trimble
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

2.  Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.

Authors:  K E Salhany; J B Cousar; J P Greer; T T Casey; J P Fields; R D Collins
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

3.  Immunopathology of cutaneous T-cell lymphomas.

Authors:  K Nasu; J Said; E Vonderheid; J Olerud; D Sako; M Kadin
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

4.  Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens.

Authors:  M Kadin; K Nasu; D Sako; J Said; E Vonderheid
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

5.  Two lymphomas: a potential diagnostic dilemma.

Authors:  A C Robinson; G H Berry
Journal:  Ir J Med Sci       Date:  1989-10       Impact factor: 1.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.